Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Hadean Ventures is a prominent European venture capital firm specializing in the life sciences sector, with approximately EUR 230 million in assets under management. Founded with the mission to address significant unmet medical needs, Hadean Ventures operates from its offices in Oslo and Stockholm, focusing on the European healthcare market. The firm has established a reputation for its strategic investments across various healthcare verticals, including biopharmaceuticals, digital health, and medical devices. With a portfolio comprising 19 innovative companies, Hadean Ventures is committed to supporting the development of groundbreaking healthcare solutions that can significantly impact patient outcomes. The firm’s leadership team brings extensive experience in venture capital and healthcare, enabling them to identify and nurture promising startups at various stages of development, from pre-seed to growth equity. Hadean Ventures distinguishes itself through its deep understanding of the healthcare landscape and its dedication to fostering innovation that meets critical medical needs.
Hadean Ventures focuses on investing in the healthcare sector, encompassing a wide range of verticals and stages of development. The firm is particularly interested in products that address significant medical needs, making it a key player in the European life sciences investment landscape. Hadean Ventures invests across multiple stages, including pre-seed, seed, seed-plus, Series A, Series B, Series C, and growth equity, allowing them to support companies at various points in their development journey. The firm seeks to partner with innovative startups that are developing solutions in areas such as biopharmaceuticals, digital health technologies, and medical devices. By targeting products that have the potential to meet unmet medical needs, Hadean Ventures aims to drive advancements in healthcare and improve patient outcomes. Their investment strategy is characterized by a thorough evaluation of market opportunities and a commitment to supporting entrepreneurs who are passionate about making a difference in the healthcare sector.
Hadean Ventures boasts a diverse portfolio of 19 companies, each contributing to advancements in the healthcare sector. Notable investments include **Actithera**, a radiopharmaceutical company, and **Alex Therapeutics**, a digital therapeutics firm based in Stockholm. The portfolio also features **Arthex Biotech**, a Spanish biopharmaceutical company focused on advanced RNA treatments, and **Attgeno**, a pharmaceutical company from Stockholm. Other significant companies include **CardioMech**, which develops innovative cardiovascular technologies, and **Cardior Pharmaceuticals**, a clinical-stage biopharmaceutical firm. Additionally, **Complement Therapeutics** and **Contineum Therapeutics** are part of the portfolio, focusing on biotechnology and therapeutic development, respectively. The firm also supports **Galecto**, a Danish drug development company, and **Neuro Event Labs**, a digital health innovator from Finland. With investments in companies like **SAGA Diagnostics** and **Themis Bioscience**, Hadean Ventures is well-positioned to influence the future of healthcare through its strategic partnerships and investments.
To pitch Hadean Ventures, founders should email enquiries@hadeanventures.com with a clear overview of their business and how it aligns with the firm's focus on healthcare innovations. It is recommended to highlight the problem being addressed and the potential impact of the solution.
Hadean Ventures invests across a wide range of stages, including pre-seed, seed, seed-plus, Series A, Series B, Series C, and growth equity. This diverse stage focus allows them to support companies at various points in their development journey.
Founders interested in pitching Hadean Ventures can reach out via email at enquiries@hadeanventures.com. It is advisable to provide a clear overview of the business, the problem it addresses, and how it aligns with Hadean's investment focus on healthcare innovations.
Hadean Ventures primarily focuses on the healthcare sector, investing in various verticals including biopharmaceuticals, digital health, and medical devices. They target products that address significant unmet medical needs.
The specific check sizes are not detailed in the source material, but Hadean Ventures invests across multiple stages, which typically suggests a range of investment amounts depending on the stage and needs of the company.
Hadean Ventures primarily invests in Europe, with a focus on the European healthcare market. Their offices in Oslo and Stockholm facilitate their engagement with startups across the region.
While specific details on portfolio support are not provided, Hadean Ventures is known for its commitment to fostering innovation in healthcare, which likely includes strategic guidance and access to their extensive network in the life sciences sector.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.